FDA Advisory Panel Backs Approval of Truvada for HIV Prevention

May 11, 2012

On May 10th, an independent advisory board of the FDA recommended approval of Truvada in preventing HIV infection in healthy people at risk of contracting the disease.  The recommendation marks the first time that the FDA will approve that drug can be prescribed for prevention of HIV that is currently used for treatment.  The FDA is expected to accept the recommendation and move forward with approval.  To read the Washington Post story, please click here.

1911 North Fort Myer Drive, Suite 900, Arlington, Virginia 22209   T: (703) 524-4744 |